XML 16 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of (Loss) Income - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Revenues        
Net earned insurance and reinsurance premiums $ 321.1 $ 282.8 $ 914.5 $ 750.6
Net investment income 21.8 12.1 51.8 44.2
Net realized investment gains (losses) 3.9 (24.4) 8.0 (26.9)
Net unrealized investment (losses) gains (11.7) (2.7) 29.0 (25.2)
Net foreign exchange (losses) gains (0.4) 15.7 21.7 17.0
Other revenue 17.0 9.5 96.0 11.8
Total revenues 351.7 293.0 1,121.0 771.5
Expenses        
Loss and loss adjustment expenses 260.4 371.2 552.8 626.6
Insurance and reinsurance acquisition expenses 59.2 49.5 189.0 143.5
Other underwriting expenses 35.7 28.7 117.1 86.6
General and administrative expenses 19.5 19.8 58.0 60.6
Intangible asset amortization expenses 3.9 3.9 11.8 6.3
Interest expense on debt 7.6 5.0 23.1 14.6
Total expenses 386.3 478.1 951.8 938.2
Pre-tax (loss) income (34.6) (185.1) 169.2 (166.7)
Income tax benefit (expense) 6.9 12.8 (55.4) 11.3
Net (loss) income (27.7) (172.3) 113.8 (155.4)
Income attributable to non-controlling interests (0.3) (4.2) (0.9) (13.2)
(Loss) income before accrued dividends on Series A redeemable preference shares (28.0) (176.5) 112.9 (168.6)
Accrued dividends on Series A redeemable preference shares   (2.5) (2.6) (3.5)
Net (loss) income attributable to Sirius Group's common shareholder $ (28.0) $ (179.0) $ 110.3 $ (172.1)
Net (loss) income per common share and common share equivalent        
Basic earnings per common share and common share equivalent $ (0.23) $ (1.49) $ 0.88 $ (1.43)
Diluted earnings per common share and common share equivalent $ (0.23) $ (1.49) $ 0.88 $ (1.43)
Weighted average number of common shares and common share equivalents outstanding:        
Basic weighted average number of common shares and common share equivalents outstanding 120,000,000 120,000,000 120,000,000 120,000,000
Diluted weighted average number of common shares and common share equivalents outstanding 120,000,000 120,000,000 120,000,000 120,000,000